Chicago VC backs Colossal Biosciences, raises $82 million fund
Crain's Chicago Business reports that a Chicago VC firm has backed Colossal Biosciences, raising a significant $82 million fund.
This investment underscores the growing potential of the biosciences sector, especially in Chicago, as it navigates the complex landscape of healthcare innovation.
As previously mentioned, the fund's creation is a testament to the vibrant and bustling nature of Chicago's emerging biotech hub. It fosters a vibrant ecosystem where game-changing ideas can metamorphose into reality.